Cardiopep Pharma GmbH
Records under this name other than patents Cardiopep Pharma GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 9 of 9 · Back to Cardiopep Pharma GmbH
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,732,406 | Use of Natriuretic Peptide for Treating Heart Failure Formerly held Term ended Term ended Nov 17, 2026 · High confidence | Term ended | Term ended Nov 17, 2026 | High confidence |
| US 8,710,006 | Use of natriuretic peptide for treating heart failure Formerly held Lapsed on the fee record Ended Apr 29, 2026 · USPTO record | Lapsed on the fee record | Ended Apr 29, 2026 | USPTO record |
| US 9,023,794 | Use of natriuretic peptide for treating heart failure Formerly held Term ended Ended no later than Apr 7, 2026 · USPTO record | Term ended | Ended no later than Apr 7, 2026 | USPTO record |
| US 6,831,064 | Use of urodilatin for treating chronic kidney failure with residual kidney functions Term ended Term ended Aug 16, 2022 · USPTO record | Term ended | Term ended Aug 16, 2022 | USPTO record |
| US 8,293,711 | Use of natriuretic peptides for treating angioedema syndromes Formerly held Lapsed on the fee record Ended Oct 23, 2020 · USPTO record | Lapsed on the fee record | Ended Oct 23, 2020 | USPTO record |
| US 7,033,997 | Use of natriuretic peptides as antibiotically active substances for the treatment of bacterial infections Lapsed on the fee record Ended Apr 25, 2014 · USPTO record | Lapsed on the fee record | Ended Apr 25, 2014 | USPTO record |
| US 5,449,751 | Cardiodilatin fragment, process for preparing same and use thereof Term ended Term ended no later than Sep 12, 2015 · Low confidence | Term ended | Term ended no later than Sep 12, 2015 | Low confidence |
| US 5,665,861 | Cardiodilatin fragment, process for preparing same and use thereof Term ended Term ended no later than Sep 9, 2017 · Low confidence | Term ended | Term ended no later than Sep 9, 2017 | Low confidence |
| US 5,767,239 | Process for preparing cardiodilatin fragments; highly purified cardiodilatin fragments and intermediate products for the preparation of same Term ended Term ended no later than Jun 16, 2018 · Low confidence | Term ended | Term ended no later than Jun 16, 2018 | Low confidence |